Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Thomas R. Riley"'
Autor:
Zakiyah Kadry, MD, Jonathan G. Stine, MD, Takehiko Dohi, MD, Ashokkumar Jain, MD, Kimberly L. Robyak, BS, Osun Kwon, MD, Christopher J. Hamilton, BS, Piotr Janicki, MD, Thomas R. Riley, III, MD, Fauzia Butt, MD, Karen Krok, MD, Ian R. Schreibman, MD, Dmitri Bezinover, MD, Nasrollah Ghahramani, MD, Stalin Campos, MD, Christopher S. Hollenbeak, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 7, p e709 (2021)
Background. Renal dysfunction is associated with poor long-term outcomes after liver transplantation. We examined the renal sparing effect of everolimus (EVR) compared to standard calcineurin inhibitor (CNI) immunosuppression with direct measurements
Externí odkaz:
https://doaj.org/article/7d77e618688c490b95ec826e70c2d2e4
Publikováno v:
Case Reports in Medicine, Vol 2015 (2015)
Although abnormal liver function tests occur in 50–80% of cases with Turner syndrome, there are no previous reports of overt hepatic disease or hepatic granulomas associated with Turner’s syndrome. We report three cases of Turner syndrome associa
Externí odkaz:
https://doaj.org/article/c1573b2c28c04ca3b35d3355a40468bf
Publikováno v:
Annals of Internal Medicine: Clinical Cases. 1
Publikováno v:
Journal of Liver Transplantation. 8:100114
Autor:
Garrett R, Leonard, Hiroko, Shike, Tadahiro, Uemura, Justine L, Gaspari, Francesca M, Ruggiero, Riaz A, Shah, Thomas R, Riley, Zakiyah, Kadry
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 19(9)
A positive crossmatch has been associated with increased risk in liver transplantation. To study the clinical significance of preformed donor-specific human leukocyte antigen antibodies (DSAs) in liver transplantation, we reviewed patients who underw
Autor:
Tadahiro, Uemura, Thomas R, Riley, Akhtar, Khan, Christopher, Hollenbeak, Ian, Schreibman, Nasrollah, Ghahramani, Brian, Reeves, Ronald E, Domen, Dani S, Zander, Zakiyah, Kadry
Publikováno v:
Clinical transplantation. 25(1)
Immunosuppression management in post-transplant malignancy is challenging because of a lack of objective immunologic assessment tools. The ImmuKnow assay measures the ATP level from CD4 T cells, quantifying cell-mediated immunity and providing an ins
Publikováno v:
Journal of gastrointestinal and liver diseases : JGLD. 18(3)
To evaluate weight history in chronic liver disease and assess for associations with advanced fibrosis. Weight and Lifestyle Inventory (WALI) was used to assess lifelong weight and eating habits.38 patients had a diagnosis of nonalcoholic fatty liver
Autor:
Thomas R, Riley, Kenneth, Koch
Publikováno v:
Digestive diseases and sciences. 48(10)
Chronic hepatitis has many causes. Symptoms include upper abdominal pain. To allow for a better understanding of this pain we compare HCV patients with other liver diseases and normal controls on their reporting of pain over one month and describe as
Autor:
Thomas R, Riley
Publikováno v:
Digestive diseases and sciences. 47(10)
The aim of this study is to identify risk factors for analgesic use following liver biopsy. In all, 121 consecutive biopsies were examined prospectively. Five variables were selected that might predict analgesia use: (1) anxiety, (2) request for seda
Autor:
Mejdi Ahmad, Thomas R Riley
Publikováno v:
The American journal of gastroenterology. 96(2)
We previously showed that ultrasound altered position of biopsy in 15% of cases by demonstrating intervening structures. This study was designed to test whether one could predict in which cases ultrasound would be useful.A standard percussion techniq